Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Boehringer Ingelheim, Lilly receive FDA approval for Trajenta to treat type 2 ... - News-Medical.net |
 |
 |
|
News-Medical.net Trajenta belongs to a class of prescription medications called dipeptidyl peptidase-4 (DPP-4) inhibitors and is the first of its class to be approved at one dosage strength with no dose adjustment required in patients with mild or moderate renal |
